This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheung, H. W. Articles by Wang, X. Search for Related Content PubMed PubMed Citation Articles by Cheung, H. W. Articles by Wang, X.

Inactivation of Human MAD2B in Nasopharyngeal Carcinoma Cells Leads to Chemosensitization to DNA-Damaging Agents

Departments of ¹ Anatomy, ² Biochemistry, ³ Clinical Oncology, and ⁴ Pathology, Faculty of Medicine, The University of Hong Kong, Hong Kong, China

Requests for reprints: Xianghong Wang, Departments of Anatomy and Biochemistry, The University of Hong Kong, 1/F, Faculty of Medicine Building, 21 Sassoon Road, Hong Kong, China. Phone: 852-2819-2867; Fax: 852-2817-0857; E-mail: xhwang{at}hkucc.hku.hk or Dong-Yan Jin, E-mail: dyjin{at}hkucc.hku.hk.

Rev7p has been suggested to play an important role in regulating DNA damage response in yeast, and recently, the human homologue (i.e., MAD2B) has been identified, which shares significant homology to the mitotic checkpoint protein MAD2. In this study, we investigated whether MAD2B played a key role in cellular sensitivity to DNA-damaging anticancer drugs by suppressing its expression using RNA interference in nasopharyngeal carcinoma cells. Using colony formation assay, we found that suppression of MAD2B conferred hypersensitivity to a range of DNA-damaging agents, especially DNA cross-linkers, such as cisplatin, and -irradiation. This effect was associated with reduced frequencies of spontaneous and drug-induced mutations, elevated phosphorylation of histone H2AX, and markedly increased chromosomal aberrations in response to DNA damage. In addition, there was also a significant decrease in cisplatin-induced sister chromatid exchange rate, a marker for homologous recombination-mediated post-replication repair in MAD2B-depleted cells. These results indicate that MAD2B may be a key factor in regulating cellular response to DNA damage in cancer cells. Our findings reveal a novel strategy for cancer therapy, in which cancer cells are sensitized to DNA-damaging anticancer drugs through inactivation of the MAD2B gene. (Cancer Res 2006; 66(8): 4357-67)

This article has been cited by other articles:

				W. K. Kwok, M.-T. Ling, H. F. Yuen, Y.-C. Wong, and X. Wang Role of p14ARF in TWIST-mediated senescence in prostate epithelial cells Carcinogenesis, December 1, 2007; 28(12): 2467 - 2475. [Abstract] [Full Text] [PDF]

				E. W. Howard, M.-T. Ling, C. W. Chua, H. W. Cheung, X. Wang, and Y. C. Wong Garlic-Derived S-allylmercaptocysteine Is a Novel In vivo Antimetastatic Agent for Androgen-Independent Prostate Cancer Clin. Cancer Res., March 15, 2007; 13(6): 1847 - 1856. [Abstract] [Full Text] [PDF]

				K. H. Kok and D.-Y. Jin Influenza A virus NS1 protein does not suppress RNA interference in mammalian cells J. Gen. Virol., September 1, 2006; 87(9): 2639 - 2644. [Abstract] [Full Text] [PDF]